{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T21:43:53Z","timestamp":1764020633153},"reference-count":23,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"DOI":"10.1007\/s00228-023-03450-2","type":"journal-article","created":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T06:02:49Z","timestamp":1673416969000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical and cost-effectiveness analysis of carbapenems versus ciprofloxacin in the treatment of urinary tract infections due to extended spectrum \u03b2-lactamase-producing Enterobacterales"],"prefix":"10.1007","author":[{"given":"Marwah H.","family":"Barnawi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abrar K.","family":"Thabit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diena M.","family":"Almasri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suha","family":"Bulbol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,11]]},"reference":[{"key":"3450_CR1","doi-asserted-by":"publisher","unstructured":"Geerlings SE (2016) Clinical presentations and epidemiology of urinary tract infections. Microbiol Spectr 4(5). https:\/\/doi.org\/10.1128\/microbiolspec.UTI-0002-2012","DOI":"10.1128\/microbiolspec.UTI-0002-2012"},{"issue":"2","key":"3450_CR2","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1517\/14656566.2015.993381","volume":"16","author":"AK Thabit","year":"2015","unstructured":"Thabit AK, Crandon JL, Nicolau DP (2015) Antimicrobial resistance: impact on clinical and economic outcomes and the need for new antimicrobials. Expert Opin Pharmacother 16(2):159\u2013177. https:\/\/doi.org\/10.1517\/14656566.2015.993381","journal-title":"Expert Opin Pharmacother"},{"issue":"4","key":"3450_CR3","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1056\/NEJMra041359","volume":"352","author":"GA Jacoby","year":"2005","unstructured":"Jacoby GA, Munoz-Price LS (2005) The new \u03b2-lactamases. N Engl J Med 352(4):380\u2013391","journal-title":"N Engl J Med"},{"key":"3450_CR4","unstructured":"World Health Organization (2017) WHO publishes list of bacteria for which new antibiotics are urgently needed. https:\/\/www.who.int\/news\/item\/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed. Accessed 1 Sept\u00a02022"},{"issue":"11","key":"3450_CR5","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.3390\/ph6111335","volume":"6","author":"I Morrissey","year":"2013","unstructured":"Morrissey I, Hackel M, Badal R, Bouchillon S, Hawser S, Biedenbach D (2013) A review of ten years of the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2002 to 2011. Pharmaceuticals (Basel) 6(11):1335\u20131346. https:\/\/doi.org\/10.3390\/ph6111335","journal-title":"Pharmaceuticals (Basel)"},{"key":"3450_CR6","volume-title":"Antimicrobial resistance: global report on surveillance","author":"World Health Organization","year":"2014","unstructured":"World Health Organization (2014) Antimicrobial resistance: global report on surveillance. Switzerland, Geneva"},{"issue":"6","key":"3450_CR7","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.jinf.2015.08.012","volume":"71","author":"E Esteve-Palau","year":"2015","unstructured":"Esteve-Palau E, Solande G, Sanchez F, Sorli L, Montero M, Guerri R et al (2015) Clinical and economic impact of urinary tract infections caused by ESBL-producing Escherichia coli requiring hospitalization: a matched cohort study. J Infect 71(6):667\u2013674. https:\/\/doi.org\/10.1016\/j.jinf.2015.08.012","journal-title":"J Infect"},{"issue":"4","key":"3450_CR8","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/jhm.2157","volume":"9","author":"SH MacVane","year":"2014","unstructured":"MacVane SH, Tuttle LO, Nicolau DP (2014) Impact of extended-spectrum beta-lactamase-producing organisms on clinical and economic outcomes in patients with urinary tract infection. J Hosp Med 9(4):232\u2013238. https:\/\/doi.org\/10.1002\/jhm.2157","journal-title":"J Hosp Med"},{"key":"3450_CR9","doi-asserted-by":"publisher","unstructured":"Karaiskos I, Giamarellou H (2020) Carbapenem-sparing strategies for esbl producers: when and how. Antibiotics (Basel) 9(2).\u00a0https:\/\/doi.org\/10.3390\/antibiotics9020061","DOI":"10.3390\/antibiotics9020061"},{"issue":"2","key":"3450_CR10","first-page":"171","volume":"34","author":"FE Al-Otaibi","year":"2013","unstructured":"Al-Otaibi FE, Bukhari EE (2013) Clinical and laboratory profiles of urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in a tertiary care center in central Saudi Arabia. Saudi Med J 34(2):171\u2013176","journal-title":"Saudi Med J"},{"key":"3450_CR11","doi-asserted-by":"publisher","first-page":"3026851","DOI":"10.1155\/2018\/3026851","volume":"2018","author":"A Alqasim","year":"2018","unstructured":"Alqasim A, Abu Jaffal A, Alyousef AA (2018) Prevalence of multidrug resistance and extended-spectrum beta-lactamase carriage of clinical uropathogenic Escherichia coli isolates in Riyadh. Saudi Arabia Int J Microbiol 2018:3026851. https:\/\/doi.org\/10.1155\/2018\/3026851","journal-title":"Saudi Arabia Int J Microbiol"},{"issue":"6","key":"3450_CR12","first-page":"956","volume":"26","author":"AA Kader","year":"2005","unstructured":"Kader AA, Angamuthu K (2005) Extended-spectrum beta-lactamases in urinary isolates of Escherichia coli, Klebsiella pneumoniae and other gram-negative bacteria in a hospital in Eastern province. Saudi Arabia Saudi Med J 26(6):956\u2013959","journal-title":"Saudi Arabia Saudi medical journal"},{"issue":"8","key":"3450_CR13","doi-asserted-by":"publisher","first-page":"811","DOI":"10.15537\/smj.2017.8.18578","volume":"38","author":"FA Mashwal","year":"2017","unstructured":"Mashwal FA, El Safi SH, George SK, Adam AA, Jebakumar AZ (2017) Incidence and molecular characterization of the extended spectrum beta lactamase-producing Escherichia coli isolated from urinary tract infections in eastern Saudi Arabia. Saudi Med J 38(8):811\u2013815. https:\/\/doi.org\/10.15537\/smj.2017.8.18578","journal-title":"Saudi Med J"},{"issue":"2","key":"3450_CR14","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ijantimicag.2019.05.004","volume":"54","author":"Y Meije","year":"2019","unstructured":"Meije Y, Pigrau C, Fernandez-Hidalgo N, Clemente M, Ortega L, Sanz X et al (2019) Non-intravenous carbapenem-sparing antibiotics for definitive treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum beta-lactamase (ESBL) or AmpC beta-lactamase: a propensity score study. Int J Antimicrob Agents 54(2):189\u2013196. https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.05.004","journal-title":"Int J Antimicrob Agents"},{"key":"3450_CR15","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ijid.2014.08.018","volume":"29","author":"T Asakura","year":"2014","unstructured":"Asakura T, Ikeda M, Nakamura A, Kodera S (2014) Efficacy of empirical therapy with non-carbapenems for urinary tract infections with extended-spectrum beta-lactamase-producing Enterobacteriaceae. Int J Infect Dis 29:91\u201395. https:\/\/doi.org\/10.1016\/j.ijid.2014.08.018","journal-title":"Int J Infect Dis"},{"issue":"10","key":"3450_CR16","doi-asserted-by":"publisher","first-page":"2848","DOI":"10.1093\/jac\/dku215","volume":"69","author":"SH Park","year":"2014","unstructured":"Park SH, Choi SM, Chang YK, Lee DG, Cho SY, Lee HJ et al (2014) The efficacy of non-carbapenem antibiotics for the treatment of community-onset acute pyelonephritis due to extended-spectrum beta-lactamase-producing Escherichia coli. J Antimicrob Chemother 69(10):2848\u20132856. https:\/\/doi.org\/10.1093\/jac\/dku215","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"3450_CR17","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1111\/ped.13911","volume":"61","author":"JH Albaramki","year":"2019","unstructured":"Albaramki JH, Abdelghani T, Dalaeen A, Khdair Ahmad F, Alassaf A, Odeh R et al (2019) Urinary tract infection caused by extended-spectrum beta-lactamase-producing bacteria: risk factors and antibiotic resistance. Pediatr Int 61(11):1127\u20131132. https:\/\/doi.org\/10.1111\/ped.13911","journal-title":"Pediatr Int"},{"issue":"2","key":"3450_CR18","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/cid\/ciac268","volume":"75","author":"PD Tamma","year":"2022","unstructured":"Tamma PD, Aitken SL, Bonomo RA, Mathers AJ, Van Duin D, Clancy CJ (2022) Infectious Diseases Society of America 2022 guidance on the treatment of extended-spectrum beta-lactamase producing Enterobacterales (ESBL-E), carbapenem-resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with difficult-to-treat resistance (DTR-P. aeruginosa). Clin Infect Dis 75(2):187\u2013212. https:\/\/doi.org\/10.1093\/cid\/ciac268","journal-title":"Clin Infect Dis"},{"issue":"1","key":"3450_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/0924-8579(92)90020-r","volume":"2","author":"RA Robson","year":"1992","unstructured":"Robson RA (1992) Quinolone pharmacokinetics. Int J Antimicrob Agents 2(1):3\u201310. https:\/\/doi.org\/10.1016\/0924-8579(92)90020-r","journal-title":"Int J Antimicrob Agents"},{"key":"3450_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2022.05.017","author":"YM Garwan","year":"2022","unstructured":"Garwan YM, Alsalloum MA, Thabit AK, Jose J, Eljaaly K (2022) Effectiveness of antimicrobial stewardship interventions on early switch from intravenous-to-oral antimicrobials in hospitalized adults: a systematic review. Am J Infect Control. https:\/\/doi.org\/10.1016\/j.ajic.2022.05.017","journal-title":"Am J Infect Control"},{"key":"3450_CR21","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.2147\/IDR.S160720","volume":"11","author":"R Azargun","year":"2018","unstructured":"Azargun R, Sadeghi MR, Soroush Barhaghi MH, Samadi Kafil H, Yeganeh F, Ahangar Oskouee M et al (2018) The prevalence of plasmid-mediated quinolone resistance and ESBL-production in Enterobacteriaceae isolated from urinary tract infections. Infect Drug Resist 11:1007\u20131014. https:\/\/doi.org\/10.2147\/IDR.S160720","journal-title":"Infect Drug Resist"},{"issue":"1","key":"3450_CR22","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1177\/8755122515599407","volume":"32","author":"ES Wiener","year":"2016","unstructured":"Wiener ES, Heil EL, Hynicka LM, Johnson JK (2016) Are fluoroquinolones appropriate for the treatment of extended-spectrum beta-lactamase-producing gram-negative bacilli? J Pharm Technol 32(1):16\u201321. https:\/\/doi.org\/10.1177\/8755122515599407","journal-title":"J Pharm Technol"},{"issue":"4","key":"3450_CR23","doi-asserted-by":"publisher","first-page":"357","DOI":"10.3947\/ic.2018.50.4.357","volume":"50","author":"H Seok","year":"2018","unstructured":"Seok H, Cha MK, Kang CI, Cho SY, Kim SH, Ha YE et al (2018) Failure of ciprofloxacin therapy in the treatment of community-acquired acute pyelonephritis caused by in-vitro susceptible Escherichia coli strain producing CTX-type extended-spectrum beta-lactamase. Infect Chemother 50(4):357\u2013361. https:\/\/doi.org\/10.3947\/ic.2018.50.4.357","journal-title":"Infection & chemotherapy"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-023-03450-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-023-03450-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-023-03450-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T06:03:01Z","timestamp":1673416981000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-023-03450-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,11]]},"references-count":23,"alternative-id":["3450"],"URL":"https:\/\/doi.org\/10.1007\/s00228-023-03450-2","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,11]]},"assertion":[{"value":"3 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The institutional review board at John Hopkins Aramco Healthcare approved the study protocol (reference no. 18\u201315).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}